Top Midday Stories: Novo Nordisk's Obesity Drug Amycretin Shows Positive Results in Clinical Trial; Texas Instruments Q4 Earnings, Revenue Decline
In This Article:
Wall Street's major market averages were little changed around midday Friday as traders look ahead t
Upgrade to read this MT Newswires article and get so much more.
A Silver or Gold subscription plan is required to access premium news articles.